| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/31/2006 | CN1778291A Oral percarbonateamide oxygen-supply agent and preparation thereof |
| 05/31/2006 | CN1778201A Composition with blue aeterio, grape seed and cassia seed |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257918C Lilyturf root polysaccharide MDG-1 and its separation method and application |
| 05/31/2006 | CN1257913C 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 05/31/2006 | CN1257912C Beta-L-2-deoxy-nucleosides for the treatment of hepatitis B |
| 05/31/2006 | CN1257908C Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 05/31/2006 | CN1257907C Ginkgo lactone compound and its preparation and medicinal composition containing it |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257903C Quinic compound containing quaternary ammonium group and its preparation and medicine use |
| 05/31/2006 | CN1257901C Tetrahydroquinoline ketopiperidine compounds and their preparation and use |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257893C PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/31/2006 | CN1257878C Pterocarya stenoptera quinone, its preparation and use |
| 05/31/2006 | CN1257737C Chinese traditional medicinal composition for treating hemicrania and its preparing process |
| 05/31/2006 | CN1257736C Sobering-up liver-protecting medicine composition for preventing chemical liver damage and its preparation process |
| 05/31/2006 | CN1257720C Capsule of Chinese traditional medicine for treating thrombus |
| 05/31/2006 | CN1257717C Medicine for treating pertinacious porking diarrhea and its preparation method |
| 05/31/2006 | CN1257716C Application of wolfberry polyose in the preparation process of gastric ulcer treating medicine |
| 05/31/2006 | CN1257715C Clindamycin metronidazole vagina effervescent tablet and its preparing method and use |
| 05/31/2006 | CN1257714C Injection of liposome of daunorubicin or hydrochloric daunorubicin and preparation method |
| 05/31/2006 | CN1257713C Flunarizine hydrochloride injection and its preparing method |
| 05/31/2006 | CN1257712C Photodynamic porphyrin antimicrobial agents |
| 05/31/2006 | CN1257711C Butyl benzene phthalein soft capsule and its preparation method |
| 05/31/2006 | CN1257710C Preparation made from effective position of red sage root, and its preparation method |
| 05/31/2006 | CN1257709C Tensicor freeze-drying formulation and its making method |
| 05/31/2006 | CN1257708C Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method |
| 05/30/2006 | USRE39113 Neuropathic pain; in humans, animals |
| 05/30/2006 | USRE39112 Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |
| 05/30/2006 | US7053243 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053230 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases |
| 05/30/2006 | US7053228 Cushing disease; antidepressant; modulate immunology response |
| 05/30/2006 | US7053219 such as 5-methyl-6-(4-methoxyphenyl)-3-pyridin-4-yl-isoxazolo[4,5-c]pyridin-4(5H)one which has metabotropic glutamic acid receptor-antagonistic effect; for treatment of anxiety disorders, psychosomatic disorders, and eating disorders |
| 05/30/2006 | US7053216 Modulators of Rho C activity |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053213 Therapeutic heterocycles |
| 05/30/2006 | US7053210 Efficient synthesis of pyropheophorbide a and its derivatives |
| 05/30/2006 | US7053207 L-ribo-LNA analogues |
| 05/30/2006 | US7053192 Crystal forms of azithromycin |
| 05/30/2006 | US7053176 Combination of C1-INH and lung surfactant for the treatment of respiratory disorders |
| 05/30/2006 | US7053131 Super critical fluids, such as CO2, are substituted either completely or partially for the oil of an oil-in-water high internal phase emulsion foam (HIPE) and inverse high internal phase emulsion foam |
| 05/30/2006 | US7053123 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 05/30/2006 | US7053122 Brain disorders; central nervous system disorders; anxiolytic agents; analgesics; sleep disorders |
| 05/30/2006 | US7053121 Phase-shifting by modulating a retinoid nuclear receptor |
| 05/30/2006 | US7053120 Use of carboxy compounds such as 2(4-acetoxyphenyl)2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents |
| 05/30/2006 | US7053119 Methods for identifying and using IKK inhibitors |
| 05/30/2006 | US7053118 Therapeutic treatment of cancer, tumor with plakolide A, an alpha -exomethylene- gamma -disubstituted- gamma -lactone; an extracts of marine sponges of the family Plakinidae; stereospecfic |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053116 Contacting cells with phenyl benzopyranone compound or or enantiomers, diastereomeric isomers or mixtures of any two or more thereof, or pharmaceutically acceptable salts thereof for blocking amyloid toxicity in cells |
| 05/30/2006 | US7053115 Precipitates is formed by adding an alcohol selecting from methanol, ethanol, isopropyl alcohol, tert-butyl alcohol and n-butyl alcohol into a dimethyl sulfoxide solution; salt formation; hypotensive agent for treating eye hypertension; stability |
| 05/30/2006 | US7053114 A modulator controls the activity of protein kinases, tyrosine kinase; enzyme inhibitors; nontoxic, solubility, formulability, bioavailability; cancer, diabetes, hepatic cirrhosis, atherosclerosis, angiogenesis, autoimmune disease and renal disease |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053112 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053108 Indoline compounds |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053106 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053102 A beta -hydroxylactone replaces the natural alpha -hydroxylactone of camptothecin; for treating colon and breast cancer |
| 05/30/2006 | US7053101 Orphan opioid receptor (orl-1) ligands; anxiety, depression, neuropathic and acute pain, migraines, asthma, improved cognition |
| 05/30/2006 | US7053100 A cis isomer of 1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine has potent activity against hepatitis B virus infection; administration by rectal, nasal, topical, transdermal, vaginal, parenteral, intravenous injection |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053097 Inhibitors of glycogen synthase 3 kinase |
| 05/30/2006 | US7053096 Compounds having selective hydrolytic potentials |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053092 Therapy for nervous system disorders; psychological disorders |
| 05/30/2006 | US7053091 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053087 Aminocycloalkyl cinnamide compounds for arrhythmia and analgesics and anesthetics |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053085 EP4 receptor agonist, compositions and methods thereof |
| 05/30/2006 | US7053084 Antagonist for preventing the deposits of amyloid protein, for treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; (2R,3S) N1-[1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-allyl-butanediamide |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7053082 Neuroprotectants for treating epilepsy, stroke, Parkinson's disease, multiple sclerosis or amyotropic lateral sclerosis; 5-(3-methyl-4-amino or nitro-phenyl)-1,3-dioxolo[4,5-h][2,3]benzodiazepine; AMPA/cainate antagonistic effect; chemical intermediates |
| 05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
| 05/30/2006 | US7053080 A mixture comprising an aryl 2-azetidinone derivatives, and other active drug for preventing obesity, and antichlesterol agents, for lowering a steroid concentration in plasma; synergistic improve method; monoamine oxidase inhibitors |
| 05/30/2006 | US7053079 Dihydroxy (3-pyridyl) borane compounds |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/30/2006 | US7053077 such as estrone sulfamate and/or estradiol sulfamate for oral administration or for use in intrauterine releasing system (IUD) |
| 05/30/2006 | US7053076 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 05/30/2006 | US7053075 Methods for reducing body fat using vitamin D compounds |
| 05/30/2006 | US7053074 Prevention of ovarian cancer by administration of a Vitamin D compound |
| 05/30/2006 | US7053073 Treatment for reactive arthritis or bursitis |
| 05/30/2006 | US7053072 Methods for the administration of amifostine and related compounds |